Prostaglandin analogues and nitric oxide contribution in the treatment of ocular hypertension and glaucoma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prostaglandin analogues and nitric oxide contribution in the treatment of ocular hypertension and glaucoma
Authors
Keywords
-
Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-04-19
DOI
10.1111/bph.14328
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Role of Nitric Oxide in the Intraocular Pressure Lowering Efficacy of Latanoprostene Bunod: Review of Nonclinical Studies
- (2018) Megan E. Cavet et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Latanoprostene bunod ophthalmic solution 0.024% for IOP lowering in glaucoma and ocular hypertension
- (2017) Paul L. Kaufman EXPERT OPINION ON PHARMACOTHERAPY
- The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
- (2017) Simon D Harding et al. NUCLEIC ACIDS RESEARCH
- Long-term Safety and Efficacy of Latanoprostene Bunod 0.024% in Japanese Subjects with Open-Angle Glaucoma or Ocular Hypertension: The JUPITER Study
- (2016) Kazuhide Kawase et al. ADVANCES IN THERAPY
- Efficacy of Latanoprostene Bunod 0.024% Compared With Timolol 0.5% in Lowering Intraocular Pressure Over 24 Hours
- (2016) John H.K. Liu et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Comparison of Latanoprostene Bunod 0.024% and Timolol Maleate 0.5% in Open-Angle Glaucoma or Ocular Hypertension: The LUNAR Study
- (2016) Felipe A. Medeiros et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Ocular hypotensive effect of the novel EP3/FP agonist ONO-9054 versus Xalatan: results of a 28-day, double-masked, randomised study
- (2016) Eydie Miller Ellis et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Vascular and autonomic dysregulation in primary open-angle glaucoma
- (2016) Louis R. Pasquale CURRENT OPINION IN OPHTHALMOLOGY
- Ocular Hypotensive Effect of ONO-9054, an EP3/FP Receptor Agonist
- (2016) Alon Harris et al. JOURNAL OF GLAUCOMA
- Latanoprostene Bunod 0.024% versus Timolol Maleate 0.5% in Subjects with Open-Angle Glaucoma or Ocular Hypertension
- (2016) Robert N. Weinreb et al. OPHTHALMOLOGY
- Evaluation of the Effect of Latanoprostene Bunod Ophthalmic Solution, 0.024% in Lowering Intraocular Pressure over 24 h in Healthy Japanese Subjects
- (2015) Makoto Araie et al. ADVANCES IN THERAPY
- A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: the VOYAGER study
- (2014) Robert N Weinreb et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Investigation of Ocular Events Associated with Taprenepag Isopropyl, a Topical EP2 Agonist in Development for Treatment of Glaucoma
- (2014) Gina M. Yanochko et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Ocular perfusion pressure in glaucoma
- (2013) Vital P. Costa et al. ACTA OPHTHALMOLOGICA
- Role of nitric oxide in optic nerve head blood flow regulation during an experimental increase in intraocular pressure in healthy humans
- (2013) Doreen Schmidl et al. EXPERIMENTAL EYE RESEARCH
- Effects of Prostaglandin Analogues on Aqueous Humor Outflow Pathways
- (2013) Nelson S. Winkler et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Diurnal and Nocturnal Variations in Aqueous Humor Dynamics of Patients With Ocular Hypertension Undergoing Medical Therapy
- (2012) Vikas Gulati et al. ARCHIVES OF OPHTHALMOLOGY
- A Phase 2, Randomized, Dose-Response Trial of Taprenepag Isopropyl (PF-04217329) Versus Latanoprost 0.005% in Open-Angle Glaucoma and Ocular Hypertension
- (2012) Ronald A. Schachar et al. CURRENT EYE RESEARCH
- Prostaglandin Analogs and Timolol-Fixed Versus Unfixed Combinations or Monotherapy for Open-Angle Glaucoma: A Systematic Review and Meta-Analysis
- (2012) Luciano Quaranta et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- A dual acting compound with latanoprost amide and nitric oxide releasing properties, shows ocular hypotensive effects in rabbits and dogs
- (2011) F. Impagnatiello et al. EXPERIMENTAL EYE RESEARCH
- Effect of PF-04217329 a prodrug of a selective prostaglandin EP2 agonist on intraocular pressure in preclinical models of glaucoma
- (2011) Ganesh Prasanna et al. EXPERIMENTAL EYE RESEARCH
- Ocular hypotensive activity of BOL-303259-X, a nitric oxide donating Prostaglandin F2α agonist, in preclinical models
- (2011) Achim H.P. Krauss et al. EXPERIMENTAL EYE RESEARCH
- A Novel Nitric Oxide Releasing Prostaglandin Analog, NCX 125, Reduces Intraocular Pressure in Rabbit, Dog, and Primate Models of Glaucoma
- (2010) Valentina Borghi et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Aqueous Humor Concentrations of Bimatoprost Free Acid, Bimatoprost and Travoprost Free Acid in Cataract Surgical Patients Administered Multiple Topical Ocular Doses of LUMIGAN® or TRAVATAN®
- (2010) Robert Faulkner et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Uveoscleral outflow – A review
- (2009) Albert Alm et al. EXPERIMENTAL EYE RESEARCH
- Endothelial dysfunction in glaucoma
- (2008) Hemma Resch et al. ACTA OPHTHALMOLOGICA
- Efficacy and Tolerability of Prostaglandin Analogs
- (2008) Florent Aptel et al. JOURNAL OF GLAUCOMA
- Prostamides (prostaglandin-ethanolamides) and their pharmacology
- (2007) D F Woodward et al. BRITISH JOURNAL OF PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now